title: Development of a reactive stroma associated with prostatic intraepithelial neoplasia in EAF2 deficient mice.
abstract: ELL-associated factor 2 (EAF2) is an androgen-responsive tumor suppressor frequently deleted in advanced prostate cancer that functions as a transcription elongation factor of RNA Pol II through interaction with the ELL family proteins. EAF2 knockout mice on a 129P2/OLA-C57BL/6J background developed late-onset lung adenocarcinoma, hepatocellular carcinoma, B-cell lymphoma and high-grade prostatic intraepithelial neoplasia. In order to further characterize the role of EAF2 in the development of prostatic defects, the effects of EAF2 loss were compared in different murine strains. In the current study, aged EAF2(-/-) mice on both the C57BL/6J and FVB/NJ backgrounds exhibited mPIN lesions as previously reported on a 129P2/OLA-C57BL/6J background. In contrast to the 129P2/OLA-C57BL/6J mixed genetic background, the mPIN lesions in C57BL/6J and FVB/NJ EAF2(-/-) mice were associated with stromal defects characteristic of a reactive stroma and a statistically significant increase in prostate microvessel density. Stromal inflammation and increased microvessel density was evident in EAF2-deficient mice on a pure C57BL/6J background at an early age and preceded the development of the histologic epithelial hyperplasia and neoplasia found in the prostates of older EAF2(-/-) animals. Mice deficient in EAF2 had an increased recovery rate and a decreased overall response to the effects of androgen deprivation. EAF2 expression in human cancer was significantly down-regulated and microvessel density was significantly increased compared to matched normal prostate tissue; furthermore EAF2 expression was negatively correlated with microvessel density. These results suggest that the EAF2 knockout mouse on the C57BL/6J and FVB/NJ genetic backgrounds provides a model of PIN lesions associated with an altered prostate microvasculature and reactive stromal compartment corresponding to that reported in human prostate tumors.
authors.affiliation: Department of Urology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America.
authors.forename: Laura E
authors.initials: LE
authors.lastname: Pascal
authors.forename: Junkui
authors.initials: J
authors.lastname: Ai
authors.forename: Khalid Z
authors.initials: KZ
authors.lastname: Masoodi
authors.forename: Yujuan
authors.initials: Y
authors.lastname: Wang
authors.forename: Dan
authors.initials: D
authors.lastname: Wang
authors.forename: Kurtis
authors.initials: K
authors.lastname: Eisermann
authors.forename: Lora H
authors.initials: LH
authors.lastname: Rigatti
authors.forename: Katherine J
authors.initials: KJ
authors.lastname: O'Malley
authors.forename: Hei M
authors.initials: HM
authors.lastname: Ma
authors.forename: Xinhui
authors.initials: X
authors.lastname: Wang
authors.forename: Javid A
authors.initials: JA
authors.lastname: Dar
authors.forename: Anil V
authors.initials: AV
authors.lastname: Parwani
authors.forename: Brian W
authors.initials: BW
authors.lastname: Simons
authors.forename: Michael M
authors.initials: MM
authors.lastname: Ittman
authors.forename: Luyuan
authors.initials: L
authors.lastname: Li
authors.forename: Benjamin J
authors.initials: BJ
authors.lastname: Davies
authors.forename: Zhou
authors.initials: Z
authors.lastname: Wang
mesh_terms: D000818:Animals; D045744:Cell Line, Tumor; D006801:Humans; D007150:Immunohistochemistry; D017403:In Situ Hybridization; D061346:Laser Capture Microdissection; D051379:Mice; D018345:Mice, Knockout; D008817:Mice, Mutant Strains; D009687:Nuclear Proteins / Q000172:deficiency / Q000235:genetics / Q000378:metabolism*; D019048:Prostatic Intraepithelial Neoplasia / Q000235:genetics / Q000378:metabolism*; D015534:Trans-Activators / Q000172:deficiency / Q000235:genetics / Q000378:metabolism*
chemical_list: C483108:FESTA protein, mouse; D009687:Nuclear Proteins; D015534:Trans-Activators